Ubs Group Ag Ice Cure Medical Ltd. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.72 - $1.36 $4,352 - $8,221	6,045 Added 40.87%	20,834 $22,000
Q3 2023 Nov 09, 2023	BUY	$0.54 - $1.33 $7,986 - $19,669	14,789 New	14,789 $7,000
Q1 2023 May 12, 2023	SELL	$1.05 - $1.49 $28,620 - $40,614	-27,258 Reduced 94.04%	1,728 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.94 - $2.6 $25,303 - $69,989	26,919 Added 1302.32%	28,986 $44,000
Q3 2022 Nov 10, 2022	SELL	$1.12 - $2.03 $1,967 - $3,566	-1,757 Reduced 45.95%	2,067 $3,000
Q2 2022 Aug 10, 2022	SELL	$1.71 - $2.47 $418 - $605	-245 Reduced 6.02%	3,824 $7,000
Q1 2022 May 16, 2022	BUY	$2.01 - $3.31 $2,287 - $3,766	1,138 Added 38.83%	4,069 $10,000
Q4 2021 Feb 14, 2022	BUY	$2.73 - $8.7 $584 - $1,861	214 Added 7.88%	2,931 $9,000
Q3 2021 Nov 15, 2021	BUY	$8.61 - $11.33 $23,393 - $30,783	2,717 New	2,717 $24,000

364K

Ticker ICCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,835,600
Market Cap $31.3M
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.